<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="128458">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01429857</url>
  </required_header>
  <id_info>
    <org_study_id>Hom-AHF-Troponin</org_study_id>
    <nct_id>NCT01429857</nct_id>
  </id_info>
  <brief_title>Prognostic Relevance of High-sensitivity Troponin in Patients With Acute Decompensated Heart Failure</brief_title>
  <official_title>Prognostic Relevance of High-sensitivity Troponin in Patients With Acute Decompensated Heart Failure</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Saarland</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Saarland</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to investigate the prognostic value of admission
      high-sensitivity troponin in patients with acute decompensated heart failure.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients admitted for acute decompensated heart failure are included in the study. After
      gaining informed consent, concentrations of high-sensitivity troponin on admission and on
      discharge are assessed. 6 months after discharged, the incidence of clinical endpoint
      (mortality of all cause and of cardiovascular cause, hospitalization) is assessed by
      telephone contact to the patient and/or the physician. The aim of the study is to
      investigate the prognostic value of high-sensitivity troponin concentration for predicting
      death and re-hospitalization.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>June 2010</start_date>
  <completion_date type="Actual">January 2012</completion_date>
  <primary_completion_date type="Actual">January 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Time to cardiovascular death or hospitalization</measure>
    <time_frame>6 Months Follow-Up</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Time to all cause death or hospitalization</measure>
    <time_frame>6 Months Follow-Up</time_frame>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">304</enrollment>
  <condition>Heart Failure</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Primary care clinic
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Hospital admission for acute cardiac decompensation

          -  Systolic and / or diastolic heart failure

        Exclusion Criteria:

          -  Myocardial infarction in the last 4 weeks

          -  Serum creatinine &gt;2.5 mg/dl

          -  Pulmonary embolism
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>89 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Innere Medizin III - Kardiologie, Angiologie und Internistische Intensivtherapie</name>
      <address>
        <city>Homburg</city>
        <state>Saarland</state>
        <zip>66421</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>June 2013</verification_date>
  <lastchanged_date>June 13, 2013</lastchanged_date>
  <firstreceived_date>February 1, 2011</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University Hospital, Saarland</investigator_affiliation>
    <investigator_full_name>Christian Ukena</investigator_full_name>
    <investigator_title>Dr. med. Christian Ukena</investigator_title>
  </responsible_party>
  <keyword>Troponin concentration in heart failure</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Heart Failure</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
